# Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/par-23-216-limited-competition-centers-of-biomedical-research/  
Official notice: https://www.grants.gov/search-results-detail/349206

> National Institutes of Health offered grants to colleges and universities. Applications closed on September 30, 2025.

| Field | Value |
|---|---|
| Opportunity number | PAR-23-216 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | September 30, 2025 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.859 |

## Who can apply

- Public and State controlled institutions of higher education

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. see NOFO for eligibility details

## What the grant funds

The purpose of this Notice of Funding Opportunity (NOFO) is to transition the core resources and biomedical research activities of Centers of Biomedical Research Excellence (COBRE) into independence and sustainability.

## Questions people ask

### Is PAR-23-216 still open?

No. It closed on September 30, 2025.

### Who can apply for Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)?

National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)?

Closed September 30, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under PAR-23-216?

NIH RePORTER lists 26 projects funded under PAR-23-216 in fiscal 2024 to 2026, at 22 institutions. The most were at University of North Dakota, University of Nebraska Lincoln, University of Delaware.

### Who has won Biomedical Research and Research Training grants before?

The largest recipients over five fiscal years were The Leland Stanford Junior University, Regents of the University of Michigan, University of California, San Diego. The program made 11,631 awards worth $15 billion in that time.
